4.7 Review

Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets

期刊

BIOMOLECULES
卷 11, 期 7, 页码 -

出版社

MDPI
DOI: 10.3390/biom11070945

关键词

ceramide; sphingolipids; Parkinson's disease; neurodegeneration; sphingomyelinase; ceramide synthase; beta-GCase; sphingolipidomics

资金

  1. Xunta de Galicia (Conselleria de Economia e Industria) [IN607A2018/3, IN607D 2020/09]
  2. Science Ministry of Spain [RTI2018-102165-B-I00, RTC2019-007373-1]
  3. INTERREG Atlantic Area [EAPA_791/2018_ NEUROATLANTIC]
  4. INTERREG V A Espana Portugal (POCTEP) [0624_2IQBIONEURO_6_E]
  5. European Regional Development Fund (ERDF)
  6. Departamento de Educacion, Universidades e Investigacion (Gobierno Vasco, Gasteiz-Virtoria, Spain) [IT-1106-16]
  7. iPFIS contract [IFI18/00008]
  8. Miguel Servet Program from the Instituto de Salud Carlos III [CPII17/00027]

向作者/读者索取更多资源

This article summarizes the role of ceramide in cellular processes and highlights its importance in neurodegenerative diseases, particularly in Parkinson's disease.
Ceramide is a bioactive sphingolipid involved in numerous cellular processes. In addition to being the precursor of complex sphingolipids, ceramides can act as second messengers, especially when they are generated at the plasma membrane of cells. Its metabolic dysfunction may lead to or be a consequence of an underlying disease. Recent reports on transcriptomics and electrospray ionization mass spectrometry analysis have demonstrated the variation of specific levels of sphingolipids and enzymes involved in their metabolism in different neurodegenerative diseases. In the present review, we highlight the most relevant discoveries related to ceramide and neurodegeneration, with a special focus on Parkinson's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据